Liminal BioSciences Inc. - stock earnings
Stock symbol LMNL is outdated, potentially delisted? Maybe it is available on other exchange?
LMNL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -9.1 million CAD | 112000 CAD |
| 2022Q4 | -4.9 million CAD | 241000 CAD |
| 2022Q3 | 21.9 million USD | 3000 USD |
| 2022Q2 | -5.9 million USD | 157000 USD |
| 2022Q1 | -10.6 million USD | ? USD |
| 2021Q4 | -17.0 million USD | 238000 USD |
| 2021Q3 | 82.2 million CAD | 170000 CAD |
| 2021Q2 | -32.0 million CAD | 25000 CAD |
| 2021Q1 | -20.3 million CAD | 210000 CAD |
LMNL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 500000 CAD | 401000 CAD |
| 2021 | 12.9 million USD | 643000 USD |
| 2020 | -117.9 million USD | 724000 USD |
| 2019 | -205.7 million USD | 745000 USD |
| 2018 | -195.4 million USD | 24.6 million USD |
| 2017 | -109.7 million CAD | 22.3 million CAD |
LMNL
Price: $8.50
52 week price:
Earnings Per Share: -8.90 USD
P/E Ratio: 0.71
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 53200
Market Capitalization: 21.0 million